Full bill text rendering is coming soon.
In the meantime, read the full text on Congress.gov ↗.
Funding / Appropriations Top 2
Authorization of appropriations
Authorizes appropriations to carry out Residential substance use disorder treatment program.
- Population Scope Low Enables funding for residential SUD treatment programs in correctional settings, directly affecting a limited subset of incarcerated individuals in participating facilities.
- Budgetary Magnitude Low Authorizes discretionary appropriations at an unspecified amount with no floor or ceiling stated in the bill text, leaving actual funding entirely to future appropriations acts.
- Legal / Regulatory Depth Low A bare authorization of appropriations creates no new substantive duty, right, or prohibition — it is a permissive fiscal vehicle with no independent legal effect.
- Degree of Discretion Granted High Congress retains full discretion over whether and how much to appropriate, and the executive retains discretion over grant awards, with no mandatory spending floor established.
- Implementation & Enforcement Burden Low No new enforcement mechanism, penalty, or compliance requirement is created by an authorization of appropriations alone.
- Temporal Commitment High As a standing authorization with no expiration date, it remains available to support future appropriations indefinitely unless Congress repeals it.
No signal yet
Regulatory or Legal Changes Top 2
Mandatory staff training as condition of grant eligibility
Requires prison and jail program staff receiving federal addiction treatment grants to complete training on addiction science, available medications, and evidence-based therapies as a condition of funding eligibility. Expands residential addiction treatment programs in prisons and jails by requiring them to offer at least one FDA-approved medication for substance use disorders and explicitly authorizing the use of any such approved medication or licensed treatment.
- Population Scope Low Directly affects only the medical officers and program staff at correctional facilities receiving Part S grants — a narrow, specialized workforce.
- Budgetary Magnitude Low No new funds are authorized or appropriated; this provision only adds eligibility conditions to an existing grant program.
- Legal / Regulatory Depth Medium Creates new statutory mandates — a staff training prerequisite and a requirement to offer at least one FDA-approved medication — as binding conditions on an existing federal grant program, constraining grantee discretion without restructuring the program.
- Degree of Discretion Granted Medium Training must be completed before or 'within a reasonable time' after receiving funds, leaving administering agencies some discretion in setting timelines while the core obligation is mandatory.
- Implementation & Enforcement Burden Medium Imposes an affirmative compliance obligation on grantees — verifying staff training completion and medication availability — that grant administrators must monitor as a condition of continued eligibility.
- Temporal Commitment High As a statutory amendment with no expiration date or reauthorization trigger, the requirements persist indefinitely until Congress acts to repeal or modify them.
No signal yet
No possible riders have been surfaced for this bill.
Summary
The STRONGER Act updates a federal grant program that funds substance use disorder (SUD) treatment inside prisons and jails. It requires programs receiving these grants to offer at least one medication approved by the Food and Drug Administration (FDA) to treat addiction. It also requires key staff to complete training on addiction science and proven therapies before or shortly after receiving funding.
AI-generated summary, pending human review.
| Version | Event | Date | User support | Your vote | Roll calls |
|---|---|---|---|---|---|
| Original |
Initial publication
Sep 24, 2026
|
Sep 24, 2026 | No votes yet | — | — |
Log in or create an account to record your vote on this legislation. Results are visible to all visitors.
Funding / Appropriations Top 2
Authorization of appropriations
Authorizes appropriations to carry out Residential substance use disorder treatment program.
- Population Scope Low Enables funding for residential SUD treatment programs in correctional settings, directly affecting a limited subset of incarcerated individuals in participating facilities.
- Budgetary Magnitude Low Authorizes discretionary appropriations at an unspecified amount with no floor or ceiling stated in the bill text, leaving actual funding entirely to future appropriations acts.
- Legal / Regulatory Depth Low A bare authorization of appropriations creates no new substantive duty, right, or prohibition — it is a permissive fiscal vehicle with no independent legal effect.
- Degree of Discretion Granted High Congress retains full discretion over whether and how much to appropriate, and the executive retains discretion over grant awards, with no mandatory spending floor established.
- Implementation & Enforcement Burden Low No new enforcement mechanism, penalty, or compliance requirement is created by an authorization of appropriations alone.
- Temporal Commitment High As a standing authorization with no expiration date, it remains available to support future appropriations indefinitely unless Congress repeals it.
No signal yet
Funding / Appropriations
Authorization of appropriations
Regulatory or Legal Changes Top 2
Mandatory staff training as condition of grant eligibility
Requires prison and jail program staff receiving federal addiction treatment grants to complete training on addiction science, available medications, and evidence-based therapies as a condition of funding eligibility. Expands residential addiction treatment programs in prisons and jails by requiring them to offer at least one FDA-approved medication for substance use disorders and explicitly authorizing the use of any such approved medication or licensed treatment.
- Population Scope Low Directly affects only the medical officers and program staff at correctional facilities receiving Part S grants — a narrow, specialized workforce.
- Budgetary Magnitude Low No new funds are authorized or appropriated; this provision only adds eligibility conditions to an existing grant program.
- Legal / Regulatory Depth Medium Creates new statutory mandates — a staff training prerequisite and a requirement to offer at least one FDA-approved medication — as binding conditions on an existing federal grant program, constraining grantee discretion without restructuring the program.
- Degree of Discretion Granted Medium Training must be completed before or 'within a reasonable time' after receiving funds, leaving administering agencies some discretion in setting timelines while the core obligation is mandatory.
- Implementation & Enforcement Burden Medium Imposes an affirmative compliance obligation on grantees — verifying staff training completion and medication availability — that grant administrators must monitor as a condition of continued eligibility.
- Temporal Commitment High As a statutory amendment with no expiration date or reauthorization trigger, the requirements persist indefinitely until Congress acts to repeal or modify them.
No signal yet
Regulatory or Legal Changes
Mandatory staff training as condition of grant eligibility
Incomplete vote
You have not made a selection on all required items:
Choose Neutral if you prefer not to commit. Leaving without completing will remove all your votes for this bill from the totals.
Maximum recommendations reached
You have already recommended the maximum number of components allowed on this bill. To recommend [new component], choose one of your current recommendations to unselect: